This inhibitory role of PPARα on DNMT1 has also been confirmed by Kong et al. showing an inhibition of DNMT1 followed by an activation of the tumor-suppressor gene CDKN2A due to lower methylation, induced by a treatment with the PPARα agonist fenofibrate [130]. The gene discussed is PPARA; the disease is neoplasm.